YAP1 and colorectal carcinoma: YAP1 has been recognised as a driver of stem-like properties in CRC [9], prompting us to explore the potential involvement of YAP1 Ser397 phosphorylation in the development of primary resistance to cetuximab through the acquisition of the CSC phenotype.